Skip to main content

Advertisement

Log in

Effects of sequential chemotherapy of FOLFIRI/FOLFOX on the endocrine axes of ACTH–cortisol and renin–angiotensin–aldosterone

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The chemotherapies of FOLFOX (leucovorin + 5-fluorouracil + oxaliplatin) and FOLFIRI (folinic acid + 5-fluorouracil + irinotecan) are effective for a variety of malignant tumors. In particular, the sequential chemotherapy of FOLFOX/FOLFIRI has become the preferred post-operational treatment approach for gastrointestinal cancer and an important palliative care program for advanced cancer. However, the sequential chemotherapy of FOLFOX/FOLFIRI showed severe side effects due to the fact that the toxicity of the drugs can be enhanced by each other. Here, we report the dynamic changes in the activities of serum ACTH, cortisol, renin, angiotensin, and aldosterone in patients following multiple cycles of FOLFOX/FOLFIRI sequential chemotherapy. We found that the sequential chemotherapy might cause damage to the activities of the endocrine cells and/or the sympathetic nerve, and alter endocrine function, specifically the ACTH–cortisol and renin–angiotensin–aldosterone axes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Donzelli E, Carfi M, Miloso M et al (2004) Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y. J Neurooncol 67:65–73

    Article  PubMed  Google Scholar 

  2. Gamelin L, Boisdron-Celle M, Delva R et al (2004) Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions:a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res 10:4055–4061

    Article  PubMed  CAS  Google Scholar 

  3. Kristyanto H, Utomo AR (2010) Pharmacogenetic application in personalized cancer treatment. Acta Med Indones 42:109–115

    PubMed  Google Scholar 

  4. Huang C, Chen L, Zhao J et al (2008) Influence of chemotherapy with FOLFOX protocoI on sex hormones of male patients and the protective effect of herbal medicines for reinforcing Shen and supplementing Qi on it. Chin J Integr Tradit West Med 28:136–138 (article in Chinese)

    Google Scholar 

  5. Huang C, Chen L, Zhao J et al (2008) Preventive effect of Zhenqifuzheng(贞 芪 扶 正) granules on chemotherapy-induced haematopoietic toxicity after colorectal cancer operation. Chin J Surg Integr Tradit West Med 14:441–446 (article in Chinese)

    Google Scholar 

  6. Donzelli E, Carfi M, Miloso M et al (2004) Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y. J Neurooncol 67:65–73

    Article  PubMed  Google Scholar 

  7. Hwang BH, Guntz JM (1997) Down regulation of corticotrophin releasing factor mRNA, but not vasopressin mRNA, in the paraventricular hypothalamic nucleus of rats following nutritional stress. Brain Res Bull 43:509

    Article  PubMed  CAS  Google Scholar 

  8. Nakase S, Kitayama I, Soya H et al (1998) Increased expression of mango cellular arginine vasopressin mRNA in paraventricular nucleus of stress-induced depression-model rats. Life Sci 63:23

    Article  PubMed  CAS  Google Scholar 

  9. Marik PE, Zaloga GP (2002) Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 122:1784–1796

    Article  PubMed  Google Scholar 

  10. Annane D, Sebille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871

    Article  PubMed  CAS  Google Scholar 

  11. Ligtenberg JJ, Zijlstra JG (2004) The relative adrenal insufficiency syndrome revisited: which patients will benefit form low-dose steroids? Curr Opin Crit Care 10:456–460

    Article  PubMed  Google Scholar 

  12. Kifor I, Moore TT, Fallo F (1991) The effect of sodium intake on angiotensin content of the rat adrenal grand. Endocrinology 128:1277–1284

    Article  PubMed  CAS  Google Scholar 

  13. Mial S, Loke KE, Slater JP et al (1999) Synergy of an lodipine and angiotensin converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts. Am J Cardiol 83:92–98

    Article  Google Scholar 

  14. Brown GC (1995) Nitric oxide regulates mitochondrial respiration and cell function by inhibiting cytochromeoxidase. FEBS Lett 369:136–139

    Article  PubMed  CAS  Google Scholar 

  15. Kerr DJ, Burt AD, Beastall GH, Holloway CD (1986) The effect of 5-fluorouracil on rat adrenal function. Med Oncol Tumor Pharmacother 3:101–104

    PubMed  CAS  Google Scholar 

  16. Jensen SA, Hasbak P, Mortensen J, Sørensen JB (2010) Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle. J Clin Oncol 28:5280–5286

    Article  PubMed  CAS  Google Scholar 

  17. Damman J, Nijboer WN, Schuurs TA et al (2011) Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. Nephrol Dial Transplant 26:2345–2354

    Article  PubMed  CAS  Google Scholar 

  18. Suzuki O, Ishii H, Kobayashi S (2011) Effects of an angiotensin 2 receptor blocker plus diuretic combination drug in chronic heart failure complicated by hypertension. J Int Med Res 39:1420–1426

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We sincerely thank Professor XT Cao for his scientific help in this work. Also, we acknowledge Dr L.F. Zhou for technical assistance. This work was supported by grants from the National Natural Science Foundation of China (#30872380, #81072495), Program for Innovative Research Team in Zhejiang Province, China (#2010R50046), the Science and Technology Project of Zhejiang province, China (#2010C33006) and the Science and Technology Project of Hangzhou, China (20091233Q10). We acknowledge Siemens and Abbott for their pharmaceutical and industry support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Changxin Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, C., Jiang, Y., Duan, G. et al. Effects of sequential chemotherapy of FOLFIRI/FOLFOX on the endocrine axes of ACTH–cortisol and renin–angiotensin–aldosterone. J Neurooncol 108, 485–490 (2012). https://doi.org/10.1007/s11060-012-0845-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-012-0845-0

Keywords

Navigation